NYSE:KEYS

Keysight Technologies Inc. (NYSE: KEYS) Overview and Financial Performance

Font: Financial Modeling Prep  • Feb 24, 2026

Market Chart
  • Keysight Technologies Inc. (NYSE: KEYS) is a leader in electronic design and test solutions, serving industries like communications, aerospace, and automotive.
  • Goldman Sachs analyst Mark Delaney sets a new price target of $322, indicating a potential increase of 31.43%.
  • Keysight reports record revenue of $1.6 billion in Q1 2026, a 23% increase year-over-year, with core revenue growth of 14%.

Keysight Technologies Inc. (NYSE: KEYS) is a leading technology company that specializes in electronic design and test solutions. The company serves a wide range of industries, including communications, aerospace, defense, and automotive. Keysight is known for its innovative solutions in AI-driven technology and next-generation connectivity. It competes with other major players in the technology sector, such as Tektronix and Rohde & Schwarz.

On February 24, 2026, Mark Delaney from Goldman Sachs set a new price target for Keysight at $322. At the time, the stock was trading at $245, suggesting a potential increase of 31.43%. This optimistic outlook aligns with Keysight's strong financial performance in the first quarter of 2026, where the company reported record revenue of $1.6 billion, a 23% increase on a reported basis.

Keysight's core revenue growth, excluding acquisitions and currency impacts, was 14%, and orders for the quarter reached $1.645 billion, reflecting a 30% increase. The company's growth is driven by advancements in AI-driven technology, next-generation connectivity, and defense modernization. The Communications Solutions Group reported a 27% increase in revenue, highlighting strong performance in commercial communications, aerospace defense, and government markets.

Despite these impressive results, the GF Value of Keysight is $172.1, indicating that the stock is significantly overvalued. Currently trading at $245, the stock has seen a daily range between $239.84 and $245.81. Over the past year, KEYS has reached a high of $248 and a low of $121.43. The company has a market capitalization of approximately $42.1 billion, with a trading volume of 2,755,287 shares.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.28
50.91%
SBFM
Sunshine Biopharma, Inc.
$0.49
34.47%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.28
-3.10%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.67
-3.31%
NVDA
NVIDIA Corporation
$221.28
-0.98%
WOK
WORK Medical Technology Group Ltd.
$0.15
-21.32%
BITO
ProShares - Bitcoin ETF
$10.64
0.38%
CXAI
CXApp Inc.
$0.23
27.36%
RGTI
Rigetti Computing, Inc.
$21.36
26.51%
NIVF
NewGenIvf Group Limited
$1.19
61.01%